Latest Breaking News On - Precision timed release - Page 6 : comparemela.com

Werth Family Investment Associates Converts $5 8 Million of Debt into Cingulate Equity at a Premium

Werth Family Investment Associates Converts $5 8 Million of Debt into Cingulate Equity at a Premium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKansas cityPeterj werthMelyssa weibleThomas daltonMatt krepsDarrow associatesExchange commissionSecurities exchangeWerth family investment associatesCingulate incElixir health public relationsCingulate therapeutics llc ctxPrecision timed releaseCingulate therapeuticsNote conversion agreement

Dr Vince Clinical Research Announces First Dosing in Cingulate Therapeutics CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients

Dr Vince Clinical Research Announces First Dosing in Cingulate Therapeutics CTx-1301 Phase III Laboratory Classroom Study in ADHD Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Brad vinceShanej schafferZach baderVince clinical research on linkedinBusiness developmentVince clinical researchContract research organizationCingulate therapeuticCingulate therapeuticsPrecision timed releaseNew drug applicationOverland parkFaster dataVince clinical

Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023

Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Kansas cityUnited statesAnn childressShanej schafferMatt krepsMelyssa weibleThomas daltonSafety laboratory classroom study in adultsExchange commissionSecurities exchangePlatform technologyDarrow associatesElixir health public relationsCingulate incDrug administrationNashville music city center

Cingulate Inc Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update

Cingulate Inc Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kansas cityUnited statesLincoln parkThomas daltonMatt krepsRaul silvaShanej schafferMelyssa weibleHc wainwright coCingulate incDarrow associatesResearch development rd expensesWerth family investment associatesElixir health public relationsSecurities exchangeUs psych congress

Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD

Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 Cingulate Inc. , a biopharmaceutical company utilizing its.

United statesKansas cityThomas daltonAnn childressShanej schafferMelyssa weibleMatt krepsExchange commissionPlatform technologyCingulate incSecurities exchangeBehavior medicine incDarrow associatesElixir health public relationsDrug administrationResults indicative